Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TADO trial of prasugrel versus placebo in pediatric sickle cell disease
PACTR201402000508243Not yet recruiting
- Sponsor
- Eli Lilly and Company
- Start
- Feb 2013
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Randomised, double-blind trial in sickle cell disease (SCD) comparing Prasugrel with Placebo (2 arms). Primary endpoint: Primary efficacy endpoint. Planned start Feb 2013; status: not yet recruiting.
02
Drugs
prasugrel
03
Conditions
sickle cell disease (SCD)
Beyond the preview
Go deeper on PACTR201402000508243.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR201402000508243.